this Comprehensive Introduction Covers All Aspects Of Biopharmaceutical Manufacturing, Including Technology And Facilities, Gmp And Regulatory Issues, As Well As Costing And Timeline Aspects For Supply Chain Implementation. written By A Leading Expert At One Of The Largest Pharmaceutical Companies
Manufacturing of Pharmaceutical Proteins: From Technology to Economy. By Stefan Behme.
✍ Scribed by Christian F. W. Becker
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 111 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1860-7179
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
this Comprehensive Introduction Covers All Aspects Of Biopharmaceutical Manufacturing, Including Technology And Facilities, Gmp And Regulatory Issues, As Well As Costing And Timeline Aspects For Supply Chain Implementation. written By A Leading Expert At One Of The Largest Pharmaceutical Companies
this Comprehensive Introduction Covers All Aspects Of Biopharmaceutical Manufacturing, Including Technology And Facilities, Gmp And Regulatory Issues, As Well As Costing And Timeline Aspects For Supply Chain Implementation. written By A Leading Expert At One Of The Largest Pharmaceutical Companies
this Comprehensive Introduction Covers All Aspects Of Biopharmaceutical Manufacturing, Including Technology And Facilities, Gmp And Regulatory Issues, As Well As Costing And Timeline Aspects For Supply Chain Implementation. written By A Leading Expert At One Of The Largest Pharmaceutical Companies
this Comprehensive Introduction Covers All Aspects Of Biopharmaceutical Manufacturing, Including Technology And Facilities, Gmp And Regulatory Issues, As Well As Costing And Timeline Aspects For Supply Chain Implementation. written By A Leading Expert At One Of The Largest Pharmaceutical Companies
this Comprehensive Introduction Covers All Aspects Of Biopharmaceutical Manufacturing, Including Technology And Facilities, Gmp And Regulatory Issues, As Well As Costing And Timeline Aspects For Supply Chain Implementation. written By A Leading Expert At One Of The Largest Pharmaceutical Companies